Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis - United States
doi 10.1177/1076029618802364
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
SAGE Publications